Juul Labs, Inc.
The Juul Labs MDL was centralized in October 2019 in the Northern District of California to coordinate personal-injury, consumer-protection, and government-entity claims alleging that the company marketed its vaping products to underage users while downplaying nicotine-addiction risk and other health harms. Over the years since, the docket moved through a series of large, sequential settlements — a multistate settlement addressing youth-marketing practices, a substantial class settlement resolving a large share of consolidated personal-injury and consumer claims, and further state-specific settlements resolving additional claim categories. With only eleven actions currently pending, the docket now sits well past its high-volume phase.
What drives resolution risk for any case still open here is almost entirely about claim eligibility and settlement-track status rather than a live general-causation dispute — the core factual and marketing-practices record that shaped the earlier settlements is well established. A remaining claim's path to resolution depends on whether it was excluded from, opted out of, or filed after the settlements that resolved the bulk of the docket, and on what distinct theory of harm (individual personal injury, government-entity public-nuisance-style claims, or otherwise) it is pursuing outside those settled tracks.
This is a clear example of a mass tort that resolved primarily through negotiated settlement rather than trial verdict, and of how a docket's structural risk profile shifts once its major settlement waves have passed: duration risk for the remaining population is now driven by individual claim posture rather than by a docket-wide bellwether or causation timeline.
Criterica Intelligence tracks this settlement-driven resolution pattern as a distinct structural category within regulated outcomes intelligence, since a docket that has resolved through sequential settlements behaves differently — and requires a different kind of structural read — than one still awaiting its first major bellwether trial, and the platform surfaces that distinction across every active MDL.
It consolidated personal-injury, consumer-protection, and government-entity claims alleging that Juul Labs marketed its vaping products to underage users while understating nicotine-addiction and health risks.
A series of large settlements over several years — covering youth-marketing practices, a broad personal-injury and consumer class, and additional state-level claims — resolved the substantial majority of the consolidated docket.
It proceeds on an individual basis, since the docket's major settlement waves have already passed; a case outside those settlements is litigated on its own specific facts and theory of harm.
The core factual record on marketing practices was substantially developed and addressed through the sequence of settlements; what remains open in individual cases is largely about eligibility and specific claim posture rather than that underlying record.
Statistics shown reflect historical or illustrative model outputs derived from real case data. They are not predictions or guarantees of any individual outcome. Litigation results depend on facts, jurisdiction, judge, and counsel, and vary case by case. Model accuracy is subject to selection effects and changing legal dynamics.